Delivery Order SPE2DB20D1100-SPE2DB24FC6R0

Award Date 7/10/24
Potential Completion Date 7/11/24
Potential Value $3.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is for the supply of CONCERTA ER 27 MG TABLET 100S to the Defense Logistics Agency (DLA). The contract, valued at $5,961.86, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a Delivery Order contract with a Firm Fixed Price pricing type, and the ultimate completion date is October 31, 2024. The contract is not designated with a set-aside requirement, indicating open competition....
This federal contract award is for the delivery of CONCERTA ER 27 MG TABLET 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $11,266.02 and a period of performance through June 7, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued...
This federal contract award is for the delivery of CONCERTA ER 27 MG TABLET 100S to the Defense Logistics Agency (DLA). The contract, valued at $8,710.22, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a period of performance through November 12, 2024. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award is for the delivery of CONCERTA ER 54 MG TABLET 100S to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $11,496.18 and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a...
This federal contract award is for the delivery of CONCERTA ER 36 MG TABLET 100S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 27, 2024 with a ceiling value of $10,843.26. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 30, 2024. This contract award does not have a set-aside...
This federal contract award is for the delivery of CONCERTA ER 27 MG TABLET 100S to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $10,207.63 and a completion date of February 8, 2024. It is a delivery order under a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award is for the delivery of CONCERTA ER 18 MG TABLET 100S to the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on October 23, 2024 with a completion date of October 24, 2024. The contract has a ceiling value of $10,131.96 and is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug...
This federal contract award is for the delivery of CONCERTA ER 27 MG TABLET 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $6,811.21, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of June 6, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp...
This federal contract award is for the delivery of CONCERTA ER 54 MG TABLET 100S medical products to the Defense Logistics Agency (DLA). The $6,334.05 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on November 25, 2024 with a completion date of November 26, 2024. The contract is a delivery order issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
This federal contract award is for the delivery of CONCERTA ER 36 MG TABLET 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $4,441.09 and a completion date of November 7, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition....
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC6R0
    Delivery Order

This federal contract award is for the delivery of CONCERTA ER 27 MG TABLET 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $3,192.08. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The subject contract award does not have a set-aside designation, indicating open competition.

Generated 5/17/25, 9:45 AM